Isaac Ro
3 verified contacts (2 professional url, 1 published business email)
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- Currentrole
Partner at Catalio Capital Management, LP.
Tenure says how settled this partner is at the firm.
- Fact Firm website
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| PrognomIQ, Inc. | Form D equity offering · $34.3M | Catalio Capital Management, LP | strongly supported · board | Aug 26, 2024 | Inference sec.gov |
| Cage Pharmaceuticals, Inc. | Form D equity offering · $137,490 | Catalio Capital Management, LP | strongly supported · board | May 31, 2024 | Inference sec.gov |
| PinkDx, Inc. | Form D equity offering · $17.0M | Catalio Capital Management, LP | strongly supported · board | Oct 20, 2023 | Inference sec.gov |
- PrognomIQ, Inc. board seat on a deal Aug 26, 2024 Inference
- Cage Pharmaceuticals, Inc. Director May 31, 2024 Fact
- PinkDx, Inc. board seat on a deal Oct 20, 2023 Inference
- Aug 26, 2024Form D equity offering in PrognomIQ, Inc. (Catalio Capital Management, LP)
- May 31, 2024Form D equity offering in Cage Pharmaceuticals, Inc. (Catalio Capital Management, LP)
- Oct 20, 2023Form D equity offering in PinkDx, Inc. (Catalio Capital Management, LP)
Relationships across DFX
on 1 other DFX graph
Isaac Ro is the same institution as 1 record in Private Equity.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…